Cigna Group [CI] stock is trading at $299.82, up 2.44%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CI shares have gain 4.38% over the last week, with a monthly amount glided 5.19%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cigna Group [NYSE: CI] stock has seen the most recent analyst activity on February 06, 2025, when Bernstein downgraded its rating to a Mkt Perform but kept the price target unchanged to $323 for it. Previously, Piper Sandler started tracking the stock with Overweight rating on June 26, 2024, and set its price target to $400. On May 30, 2024, Robert W. Baird initiated with a Outperform rating and assigned a price target of $388 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $393 on March 06, 2024. RBC Capital Mkts upgraded its rating to a Outperform and raised its price target to $354 on February 05, 2024. Cantor Fitzgerald upgraded its rating to Overweight for this stock on February 05, 2024, and upped its price target to $372. In a note dated February 01, 2024, Deutsche Bank upgraded an Buy rating on this stock and boosted its target price from $355 to $370.
Cigna Group [CI] stock has fluctuated between $262.03 and $370.83 over the past year. Currently, Wall Street analysts expect the stock to reach $356.6 within the next 12 months. Cigna Group [NYSE: CI] shares were valued at $299.82 at the most recent close of the market. An investor can expect a potential return of 18.94% based on the average CI price forecast.
Analyzing the CI fundamentals
Cigna Group [NYSE:CI] reported sales of 194.41B for the trailing twelve months, which represents a drop of -69.18%. Gross Profit Margin for this corporation currently stands at 0.23% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.07 and Total Capital is 0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.78.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 295.24 points at the first support level, and at 290.67 for the second support level. However, for the 1st resistance point, the stock is sitting at 302.48, and for the 2nd resistance point, it is at 305.15.
Ratios To Look Out For
For context, Cigna Group’s Current Ratio is 0.86. Considering the valuation of this stock, the price to sales ratio is 0.43, the price to book ratio is 2.00 and price to earnings (TTM) ratio is 24.50.
Transactions by insiders
Recent insider trading involved Triplett Michael W, Former Officer, that happened on Feb 03 ’25 when 2506.0 shares were purchased. Director, DeLaney William J III completed a deal on Aug 19 ’24 to sell 2691.0 shares. Meanwhile, Director DeLaney William J III bought 2691.0 shares on Aug 19 ’24.
